AI assistant
Sending…
NANOVIRICIDES, INC. — Director's Dealing 2011
Oct 17, 2011
34915_dirs_2011-10-17_28f23c94-5713-459f-b688-886d4a1c8b49.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2011-10-14
Reporting Person: Diwan Anil (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-14 | Common Stock | S | 18000 | $0.83 | Disposed | 6756420 | Direct |
| 2011-10-17 | Common Stock | S | 39375 | $0.78 | Disposed | 6717045 | Direct |
Footnotes
F1: Does not include 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.
More from NANOVIRICIDES, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
Feb 17
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 22
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Nov 26